FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA Proposes to Exclude GLP 1s From 503B Bulk List Drug Topics They Call It the "Wolverine Peptide". Everyone From Joe Rogan to Pro Athletes Is Using It (And the FDA Just Banned It)